HUTCHMED (China) (HMDCF) EBT (2015 - 2021)
HUTCHMED (China)'s (HMDCF) quarterly EBT came in at -$252.5 million in Q4 2021, down 242.5% quarter-over-quarter from $177.2 million in Q3 2021.
Analysis
HUTCHMED (China) (HMDCF) EBT (2015 - 2021) Analysis & Trends
HUTCHMED (China) (HMDCF) has reported EBT for 6 consecutive years, with -$252.5 million the latest figure, recorded in Q4 2021.
- On a quarterly basis, EBT changed N/A year-over-year to -$252.5 million in Q4 2021; TTM through Dec 2021 was -$215.7 million, a N/A change from a year earlier, with the FY2025 full-year figure at $498.7 million, up 45148.87% from the prior year.
- EBT was -$252.5 million for Q4 2021 at HUTCHMED (China), down from $177.2 million in the prior quarter.
- Over five years, EBT peaked at $177.2 million in Q3 2021 and troughed at -$252.5 million in Q4 2021.
- A 4-year average of -$24.8 million and a median of -$32.8 million in 2019 frame the typical range for EBT.
- The widest YoY moves for EBT: up 246.24% in 2019, down 362.17% in 2019.
- Over 4 years, EBT stood at $23.1 million in 2018, then slumped by 266.79% to -$38.5 million in 2019, then slipped by 17.67% to -$45.3 million in 2020, then plunged by 457.79% to -$252.5 million in 2021.
- The last three EBT figures came in at -$252.5 million (Q4 2021), $177.2 million (Q3 2021), and -$77.5 million (Q2 2021), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 212.20 Bn | 198.21 Bn | 7.24 Bn | 2.77 Bn |
| 2 | Gilead Sciences | 181.83 Bn | 178.65 Bn | 6.22 Bn | -10.25 Bn |
| 3 | Vertex Pharmaceuticals | 132.47 Bn | 124.61 Bn | 2.84 Bn | 1.39 Bn |
| 4 | Regeneron Pharmaceuticals | 82.56 Bn | 74.56 Bn | 3.93 Bn | 1.53 Bn |
| 5 | Argenx Se | 61.59 Bn | 56.40 Bn | 1.37 Bn | 542.00 Mn |
| 6 | Moderna | 54.65 Bn | 49.51 Bn | 52.00 Mn | -767.00 Mn |
| 7 | Alnylam Pharmaceuticals | 34.13 Bn | 30.82 Bn | 992.69 Mn | 177.81 Mn |
| 8 | Biogen | 31.42 Bn | 30.13 Bn | 1.96 Bn | 132.40 Mn |
| 9 | Roivant Sciences | 30.21 Bn | 30.21 Bn | 1.16 Mn | -294.56 Mn |
| 10 | HUTCHMED (China) | 376.85 Mn | 391.04 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2021 | -252.46 Mn |
| Sep 28, 2021 | 177.16 Mn |
| Jun 30, 2021 | -77.54 Mn |
| Mar 31, 2021 | -62.91 Mn |
| Jun 30, 2020 | -45.26 Mn |
| Mar 31, 2020 | -31.32 Mn |
| Dec 31, 2019 | -38.47 Mn |
| Sep 30, 2019 | -34.34 Mn |
| Jun 30, 2019 | -103.21 Mn |
| Mar 31, 2019 | 34.91 Mn |
| Dec 31, 2018 | 23.06 Mn |
| Sep 30, 2018 | 13.10 Mn |
| Jun 30, 2018 | 74.37 Mn |
| Mar 31, 2018 | -23.87 Mn |
| Jun 30, 2016 | 35.48 Mn |
| Jun 30, 2015 | 27.74 Mn |